Matthias Merker

Genomic insights into the plasmidome of non-tuberculous mycobacteria - Genome Medicine Background Non-tuberculous mycobacteria (NTM) are a diverse group of environmental bacteria that are increasingly associated with human infections and difficult to treat. Plasmids, which might carry r...

genomemedicine.biomedcentral.com/articles/10....
Check out our new paper on plasmids in non-tuberculous mycobacteria!

From DNA to microbiome profiles in two days. Great workshop by Meriem Belheouane @fzborstel.bsky.social at UNAM🇳🇦. Thanks to all trainees from 10 African partner sites and the PANGenS consortium.

Season’s Greetings from the European Society of #Mycobacteriology (ESM), and best wishes for 2025! It has been another busy year for ESM and a pleasure to see so many of you at our Annual Congress in Bruges! Save the date for next ESM Annual Congress, 22–25 June 2025 in Lisbon, Portugal.
#ESMyco

Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae - Genome Medicine Background Haemophilus influenzae is an opportunistic bacterial pathogen that can cause severe respiratory tract and invasive infections. The emergence of β-lactamase-negative ampicillin-resistant (BL...

How does Haemophilus influenzae evolve mutational resistance to antibiotics like ampicillin? Difficulties with clinical breakpoints and some new genes that may play a role for other beta-lactam antibiotics as well.
@mdiricks.bsky.social @fzborstel.bsky.social

Am FZB untersuchen wir die Evolution von
#Antibiotikaresistenzen, z.B. im Mikrobiom oder bei Lungenpathogenen wie Haemophilus influenzae. Diese Bakterien können schwere Erkrankungen, wie Lungenentzündung oder #Sepsis hervorrufen und weisen zunehmend Resistenzen gegen Breitbandantibiotika auf.
#AMR